Regarding histological subtypes, our in vitro data suggests that ESCC exhibits the highest relative increase in surface PD-L1 expression following CRT and may therefore derive the greatest benefit from subsequent immunotherapy. This evidence concerns the gene CD274 and esophageal squamous cell carcinoma.